Related Experiment Video
Updated: Jul 4, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
The double-edged sword effect of estrogen in kidney disease and its precision modulation
Jinlan Zhang1,2, Jiayi Lyu1,2, Miao Deng2
1People's Hospital of Qianxinan Prefecture, Xingyi, Guizhou, China.
Abstract:
Estrogen, a critical sex hormone, exerts a complex dual role in renal physiology and pathology. While it confers protective effects through anti-inflammatory, anti-fibrotic, and hemodynamic-related signaling pathways-slowing chronic kidney disease (CKD) progression and improving renal function-it may also promote disease under specific pathological contexts. Sexual dimorphism, mediated primarily by estrogen receptor (ER) signaling networks, plays a pivotal role in this duality. This review focuses on the molecular mechanisms of estrogen in kidney disease, the influence of sexual dimorphism, and the double-edged nature of its effects, with an emphasis on precision modulation strategies. By integrating recent basic and clinical findings, we analyze the diverse roles of estrogen across kidney disease models and evaluate its therapeutic potential. Furthermore, we discuss the prospects of applying sex-based precision medicine to kidney disease management, aiming to provide theoretical foundations and guidance for future research and clinical practice.
Related Concept Videos
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
